This article is part of a Chronicle. See more from this Chronicle
Susan Creighton, Scott Russell, Feb 14, 2008
The pharmaceutical industry remains under close examination by antitrust enforcers on both sides of the Atlantic. The U.S. Federal Trade Commission’s (FTC) enforcement activities – challenging both unilateral and concerted action undertaken by pharmaceutical firms – have been ongoing for more than a decade. Concerns regarding anticompetitive conduct by pharmaceutical f
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.138.174.95
Please verify email or join us to access premium content!